News

Celltrion's autoimmune disease treatment, SteQeyma, has been launched in five major European nations, the Korean company said Thursday.
Prednisone alone or a lower dose in combination with azathioprine is the mainstay treatment for all forms of autoimmune hepatitis.
Chimeric antigen receptor (CAR) T-cell therapy has been an exciting area of development for autoimmune disease treatment. Previous reports had not mentioned any particular constellation of adverse ...
A revolutionary treatment for autoimmune diseases could be on the horizon. Twenty-four million to 50 million Americans have an autoimmune disease, in which the body’s immune system mistakenly ...
IgA Nephropathy (IgAN) is a common kidney disease and a main cause of kidney failure and chronic kidney disease. Read more about its symptoms, causes, risk factors, complications and treatments.
Is UC Autoimmune? Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage ...
Erin Moriarty of 'The Boys' fame reveals her Graves' disease diagnosis and the positive impact of treatment she is getting for the autoimmune disorder.
Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the United States alone, it disrupts the lives of about 1.
Local immune effector cell–associated toxicity syndrome is a newly identified side effect observed in many patients receiving CD19-targeting CAR T-cell therapy for autoimmune conditions.
A new study finds that women with rheumatoid arthritis, lupus, or other autoimmune conditions have twice the risk of dying from heart disease as men.
Discover why thinning eyelashes could signal serious health problems like thyroid disease, autoimmune conditions, and deficiencies.
This Autoimmune Disease Has Ravaged Women For Centuries. New Treatments Could Finally Change That. The medications don't cure the disease, but they're making the impossible seem possible.